Liposuction in obese patients

Liposuction is one of the more common elective surgical procedures in the US and is supposed to be on the increase. There are no reported studies specifically addressing the metabolic sequelae of liposuction in obesity. The aim of the present study was to investigate the role of large-volume liposuction on insulin resistance and circulating inflammatory markers in obese people. Thirty healthy premenopausal obese (body mass index (BMI) from 30 to 45) and 30 age-matched normal weight (BMI<25) women were studied. In obese women, insulin sensitivity, as measured by the Homeostasis Model Assessment (HOMA=fasting plasma glucose x fasting serum insulin divided by 25), as well as serum adiponectin, the novel adipocytokine with insulin sensitising properties, were significantly lower, as compared with nonobese women (p<0.01), indicating insulin resistance; on the contrary, serum concentrations of the proinflammatory cytokines IL-6, IL-18 and TNF-alpha, as well as the sensitive marker of inflammation C-reactive protein, were significantly higher (p<0.01). All obese women were submitted to a single large volume liposuction (superwet technique): the mean aspirate volume was 3540 ml (range 2550-4670), corresponding to a net lipid loss of 2.7+/-0.7 kg (mean+/-SD). After six months of stable body weight after liposuction, women were less insulin resistant (p<0.05), had reduced concentrations of IL-6, IL-18, TNF-alpha and CRP (p<0.05-0.02), and increased serum levels of adiponectin (p<0.02) and HDL-cholesterol (p<0.05). There was a significant correlation between the amount of fat aspirate and changes in HOMA (r=0.28, p<0.05), TNF-alpha (r=0.31, p<0.02), and adiponectin (r=-0.34, p<0.02), as well as between the decrease in TNF-alpha and the increase in adiponectin after the surgical procedure (r=-0.45, p<0.01). Our study demonstrates that liposuction is safe and free of metabolic sequelae in obese women, pending a careful screening of the patient. Moreover, it is associated with amelioration of insulin resistance and reduced circulating markers of vascular inflammation which may help obese subjects to reduce their cardiovascular risk.

For more information visit www.drlanzer.com

Vaser Liposuction - Gently reshape your body by emulsifying the fat.

Latest breakthrough in liposculpture

• Liquefies and melts fat
• Rapid healing
• Promotes smooth result
• Enhances skin retraction and tightening

Dr Lanzer has been investigating personally the new state of the art Vaser for enhanced liposculpture. The third generation high frequency ultrasound is combined with the tumescent liposculpture method to enhance healing and results. Dr Lanzer explained that the Vaser targets the Fat only and so is safe.

The procedure can be done awake or asleep depending on patients preference.
Markings are done before the procedure as in regular liposculpture and particular attention is given to where the fat bulges and where extra skin contraction is needed.
The fat is filled with the tumescent fluid that was developed by co- dermatologist some 20 years ago. Dr Lanzer says that the fluid make liposuction much safer and allowed us to remove more fat and more evenly and from new areas such as the breast. At this point the Vaser is passed through the fat layer emulsifying it into a soft liquid which is then gently removed.
The Vaser not only liquefies the fat but also stimulates the collagen to tighten and contract.

The Vaser technology is also combined with the new concept of Hi Def whereby Dr Lanzer sculptures between muscle groups to enhance the athletic appearance. It most dramatic result is on stomach to produce the “6 pack” look or the natural grooves on women’s stomach. The vaser Hi Def is also very effective for love handle removal and Man Boobs.
Female Breast enlargement normally requires an implant. The Vaser Hi Def can also give an enlarging result to the breast by sculpturing around the breast and possibly with fat injection into the breast.

For more information visit www.drlanzer.com